Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Edelman Joseph
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   43    
Direct Shares   630,171    

Indirect Shares

   337,350,545      
Direct Value   $388,435    

Indirect Value

   $2,779,157,678      
Total Shares   337,980,716      
Total Value   $2,779,546,113      


Aegerion Pharmaceuticals, Inc. $0 Nautilus Biotechnology, Inc $388,435 Aegerion Pharmaceuticals, Inc. $0 Nautilus Biotechnology, Inc $388,435
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    49   
    8    

     Stock price went up :
    33   
    4    
     Stock price went down :
    16   
    4    
   
     Gain/Loss Ratio :
   2.1   
   0.0   
     Percentage Gain/Loss :
   8.7%
 376.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Penwest Pharmaceuticals Co PPCO 10% Owner 2008-06-23 0 2008-06-23 6,387,546    Premium*  
            Synageva BioPharma Corp GEVA 10% Owner 0 2011-11-02 0    Premium*  
            Aegerion Pharmaceuticals, Inc. AEGR 10% Owner 2012-11-01 133,133 2012-11-29 2,595,293    Premium*  
            Acelrx Pharmaceuticals Inc ACRX 10% Owner 0 2017-06-19 4,533,728    Premium*  
            Amicus Therapeutics Inc FOLD 10% Owner 0 2018-10-03 20,724,424    Premium*  
            VBI Vaccines Inc VBIV 10% Owner 0 2014-07-25 2,610,356    Premium*  
            Aldeyra Therapeutics, Inc. ALDX 10% Owner 0 2025-04-03 5,875,851    Premium*  
            Aravive Inc ARAV 10% Owner 0 2017-09-22 2,099,563    Premium*  
            Kadmon Holdings, Llc KDMN 10% Owner 0 2019-11-18 14,636,334    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2017-09-29 0 2018-08-10 4,070,357    Premium*  
            Global Blood Therapeutics, Inc. GBT 10% Owner 2017-12-19 0 2017-12-19 4,889,066    Premium*  
            Corium International, Inc. CORI 10% Owner 2018-01-16 0 2018-10-12 2,724,686    Premium*  
            Albireo Pharma Inc ALBO 10% Owner 2018-01-25 0 2022-10-13 1,939,723    Premium*  
            Solid Biosciences Inc SLDB Director, 10% Owner 2018-01-30 0 2025-02-19 11,906,646    Premium*  
            La Jolla Pharmaceutical Co LJPC 10% Owner 2018-02-13 0 2019-01-08 2,253,376    Premium*  
            Motus Gi Holdings Inc MOTS 10% Owner 2018-02-16 0 2021-01-22 2,660,542    Premium*  
            Quotient Ltd QTNTQ 10% Owner 2018-05-22 0 2022-10-31 7,945,211    Premium*  
            Dova Pharmaceuticals, Inc. DOVA 10% Owner 2018-06-04 0 2019-11-12 0    Premium*  
            Meiragtx Holdings Plc MGTX Director, 10% Owner 2018-06-08 0 2024-08-12 12,531,103    Premium*  
            Crinetics Pharmaceuticals, Inc. CRNX 10% Owner 2018-07-20 0 2022-04-18 5,321,032    Premium*  
            Agile Therapeutics Inc AGRX 10% Owner 2018-07-26 0 2021-10-13 21,654,485    Premium*  
            Verrica Pharmaceuticals Inc. VRCA 10% Owner 2018-06-19 0 2023-12-29 7,099,182    Premium*  
            Athenex, Inc. ATNX 10% Owner 2019-05-06 0 2020-09-14 13,532,467    Premium*  
            ADMA Biologics Inc ADMA 10% Owner 2019-05-21 0 2021-09-30 13,262,375    Premium*  
            Foamix Pharmaceuticals Ltd FOMX 10% Owner 0 2019-07-29 11,203,881    Premium*  
            Lyra Therapeutics, Inc. LYRA Director, 10% Owner 2020-05-05 0 2023-05-31 12,757,563    Premium*  
            VYNE Therapeutics Inc VYNE 10% Owner 2020-06-09 0 2021-08-16 4,935,057    Premium*  
            Leap Therapeutics, Inc. LPTX 10% Owner 2020-06-22 0 2020-06-22 8,476,496    Premium*  
            Athira Pharma, Inc. ATHA Director, 10% Owner 0 2023-12-29 5,402,964    Premium*  
            Cerevel Therapeutics Holdings, I... CERE Director 2020-10-20 0 2024-02-20 10,794,876    Premium*  
            Scynexis Inc SCYX 10% Owner 2021-01-20 0 2021-01-22 1,800,000    Premium*  
            Landos Biopharma, Inc. LABP Director, 10% Owner 0 2021-02-09 17,960,839    Premium*  
            Astria Therapeutics, Inc ATXS Director 0 2024-02-01 6,485,420    Premium*  
            Prometheus Biosciences, Inc. RXDX 10% Owner 2021-03-16 0 2021-03-16 3,314,032    Premium*  
            Rain Therapeutics Inc. RAIN 10% Owner 2021-04-27 0 2021-10-12 2,487,019    Premium*  
            Nautilus Biotechnology, Inc NAUT 10% Owner 2021-05-24 497,038 2021-12-08 9,111,151    Premium*  
            Isoplexis Corp ISO 10% Owner 2021-10-12 0 2021-10-12 3,554,587    Premium*  
            Lianbio LIAN Director, 10% Owner 0 2024-02-15 57,575,533    Premium*  
            Acrivon Therapeutics, Inc. ACRV 10% Owner 0 2025-05-01 3,104,139    Premium*  
            Chembio Diagnostics Inc CEMI Former 10% Owner 2023-04-04 0 2023-04-27 0    Premium*  
            Soleno Therapeutics Inc SLNO 10% Owner 0 2023-06-06 2,207,753    Premium*  
            Cargo Therapeutics, Inc. CRGX Former 10% Owner 2023-11-14 0 2023-11-14 333,333    Premium*  
            Orchestra BioMed Holdings Inc. OBIO 10% Owner 0 2024-07-11 4,592,556    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACRV Acrivon Therapeutics, Inc... 10% Owner   –       –       •   2025-05-01 4 S $1.34 $400,507 I/I (298,886) 3,104,139 0 %
ACRV Acrivon Therapeutics, Inc... 10% Owner   –       –       •   2025-04-30 4 S $1.41 $617,412 I/I (437,881) 3,403,025 0 %
ACRV Acrivon Therapeutics, Inc... 10% Owner   –       –       •   2025-04-29 4 S $1.41 $352,500 I/I (250,000) 3,840,906 0 %
ACRV Acrivon Therapeutics, Inc... 10% Owner   –       –       •   2025-04-28 4 S $1.56 $335,841 I/I (215,283) 4,090,906 0 %
ACRV Acrivon Therapeutics, Inc... 10% Owner   –       –       •   2025-04-25 4 S $1.95 $2,056,605 I/I (1,054,669) 4,306,189 0 %
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2025-04-03 4 S $1.42 $4,828,000 I/I (3,400,000) 5,875,851 0 %
SLDB Solid Biosciences Inc Director   –       •       •   2025-02-19 4 B $4.03 $20,150,000 I/I 5,000,000 11,833,539 2.25 %
MGTX Meiragtx Holdings Plc Director   –       •       •   2024-08-12 4 B $4.00 $5,000,000 I/I 1,250,000 12,531,103 2.25 %
OBIO Orchestra BioMed Holdings... 10% Owner   –       –       •   2024-07-11 3 IO $0.00 $0 I/I 0 4,592,556 %
ACRV Acrivon Therapeutics, Inc... 10% Owner   –       –       •   2024-04-11 4 B $8.50 $20,000,500 I/I 2,353,000 5,360,858 1.5 %
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2024-04-05 4 B $4.74 $178,755 I/I 37,712 9,275,851 1.5 %
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2024-04-04 4 B $4.67 $655,112 I/I 140,281 9,238,139 1.5 %
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2024-04-03 4 B $4.09 $1,267,274 I/I 309,847 9,097,858 1.5 %
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2024-04-02 4 B $3.44 $640,015 I/I 186,051 8,788,011 1.5 %
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2024-04-01 4 B $3.25 $27,216 I/I 8,374 8,601,960 1.5 %
CERE Cerevel Therapeutics Hold... Director   –       •      –    2024-02-20 4 GD $0.00 $0 I/I 170,317 0 0 -
LIAN Lianbio Director   –       •       •   2024-02-15 4 D $4.76 $182,955 I/I (38,436) 17,082 0 -
LIAN Lianbio Director   –       •       •   2024-02-15 4 OE $2.52 $182,952 I/I 72,600 36,300 0 -
ATXS Astria Therapeutics, Inc Director   –       •      –    2024-02-01 4 B $12.09 $29,999,522 I/I 2,481,350 4,873,721 2.1 %
SLDB Solid Biosciences Inc Director   –       •       •   2024-01-11 4 B $5.53 $18,861,243 I/I 3,410,713 6,833,539 2.25 %
VRCA Verrica Pharmaceuticals I... 10% Owner   –       –       •   2023-12-29 4 B $7.24 $838,204 I/I 115,774 7,099,182 1.5 %
ATHA Athira Pharma, Inc. Director   –       •       •   2023-12-29 4 B $2.38 $390,211 I/I 163,954 5,402,964 2.25 -
VRCA Verrica Pharmaceuticals I... 10% Owner   –       –       •   2023-12-28 4 B $7.08 $892,901 I/I 126,116 6,983,408 1.5 %
ATHA Athira Pharma, Inc. Director   –       •       •   2023-12-28 4 B $2.44 $999,419 I/I 409,598 5,239,010 2.25 -
VRCA Verrica Pharmaceuticals I... 10% Owner   –       –       •   2023-12-27 4 B $7.20 $574,027 I/I 79,726 6,857,292 1.5 %
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us